Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)

NCT01177384 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin phosphate
DRUG: Comparator: Placebo
DRUG: Acarbose
DRUG: Glimepiride

Sponsor

Merck Sharp & Dohme LLC